ARPA-H, the United States' "moonshot" agency dedicated to advancing scientific research and development, has launched a new project aimed at developing custom gene editing drugs. According to [1], this effort is part of ARPA-H's broader mission to accelerate progress in biotechnology and medicine. [2] does not provide specific details about the scope or potential applications of these gene editing drugs but notes that the initiative will focus on advancing existing technologies rather than creating entirely new ones. The announcement comes amid growing interest in gene editing as a tool for treating genetic diseases. [1] highlights that this investment is part of ARPA-H's efforts to support innovative research and development, which could lead to significant advancements in medical treatments.